[4]?OMER M M , CRYSTAL D, REEM S M H A D, et al. An update on the role of irisin in the regulation of endocrine and metabolic functions[J]. Peptides, 2018, 104: 15-23.?/div>
[5]?SEALE P, CONROE H M, ESTALL J, et al. Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice[J]. Journal of Clinical Investigation, 2011, 121(1): 96-105.
[6]?ENERBACK S. Human brown adipose tissue[J]. Cell Metabolism, 2010, 11(4): 248-252.?/div>
[7]?LUO Y Y, QIAO X Y, MA Y X, et al. Disordered metabolism in mice lacking irisin[J]. Scientific Reports, 2020, 10(1): 17368.
[8]?LIU J J, WONG M D S, WAN C T, et al. Lower circulating irisin is associated with type 2 diabetes mellitus[J]. Journal of Diabetes and Its Complications, 2013, 27(4): 365-369.
[9]?YANG Z G, CHEN X, CHEN Y J, et al. Decreased irisin secretion contributes to muscle insulin resistance in high-fat diet mice[J]. International Journal of Clinical and Experimental Pathology, 2015, 8(6): 6490-6497.
[10] WHINCUP P H, KAYE S J, OWEN C G, et al. Birth weight and risk of type 2 diabetes: A systematic review[J]. Journal of the American Medical Association, 2008, 300(24): 2886-2897.
[11] Aydiny S, KULOGLU T, AYDIN S. Copeptin, adropin and irisin concentrations in breast milk and plasma of healthy women and those with gestational diabetes mellitus[J]. Peptides, 2013, 47: 66-70.
[12] ZHANG C, NING Y. Effect of dietary and lifestyle factors on the risk of gestational diabetes: review of epidemiologic evidence[J]. American Journal of Clinical Nutrition, 2011, 94(6S): 1975-1979.
[13] TANG NU, CHEN YAJUN, WU WEIJIA, et al. Association between plasma irisin in pregnancy and postpartum glucose levels among Chinese women: A cohort study[J]. Journal of diabetes investigation,2021,12(9).
[14] ZHAO L, LI J, LI Z L, et al. Circulating irisin is lower in gestational diabetes mellitus[J]. Endocrine Journal, 2015, 62(10): 921-926.
[15] LAAKSO M, KUUSISTO J. Insulin resistance and hyperglycaemia in cardiovascular disease development[J]. Nature Reviews Endocrinology, 2014, 10(5): 293-302.
[16] PERAKAKIS N, TRIANTAFYLLOU G A, FERNANDEZ-REAL J M, et al. Physiology and role of irisin in glucose homeostasis[J]. Nature Rviews Endocrinology, 2017, 13(6): 324-337.
[17] TEREZA P, FILIP Z, JOSEF T, et al. Irisin maternal plasma and cord blood levels in mothers with spontaneous preterm and term delivery[J]. Disease Markers, 2018, 2018: 7628957.
[18] MOL N, ZASADA M, TOMASIK P, et al. Evaluation of irisin and visfatin levels in very low birth weight preterm newborns compared to full term newborns-A prospective cohort study[J]. PloS one, 2018, 13(9): e0204835.
[19] SHAN D, LIU X J, CAI Y T, et al. Irisin level and neonatal birthweight: A systematic review and meta-analysis[J]. European Journal of Obstetrics and Gynecology and Reproductive Biology, 2020, 254: 25-32.
[20] 吴红花,郭晓蕙. 妊娠期糖尿病的前世、今生与未来[J].中华糖尿病杂志,2020,12(7): 433-435.
[21] GHIO A, BERTOLOTTO A, RESI V, et al. Triglyceride metabolism in pregnancy[J]. Advances in Clinical Chemistry, 2011, 55: 133-153.
[22] 杨勇平,王剑芬,李彩凤,等. 妊娠期糖尿病孕妇孕中晚期血脂水平变化及对新生儿出生体重的影响[J]. 吉林医学,2020,41(10): 2355-2357.
[23] DEIERLEIN A L, SIEGA-RIZ A M, CHANTALA K, et al. The association between maternal glucose concentration and child BMI at age 3 years[J]. Diabetes Care, 2011, 34(2): 480-484.
[24] HAWTHORNE G, ROBSOB S, RYALL E A, et al. Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit, 1994[J]. British Medical Journal 1997, 315(7103): 279-281.
[25] MARTINT J, ELLIOT D. Creating an overall measure of severity of disability for the office of population censuses and surveys disability survey[J]. Journal of the Royal Statistical Society, 1992, 155(1): 121-140.
[26] 张庆环,徐一玲. 运动疗法联合饮食干预对妊娠期糖尿病患者血糖控制及母婴结局的影响[J]. 数理医药学杂志,2021,34(10): 1543-1545.
[27] TIMMONS J A, BAAR K, DAVIDSEN P K, et al. Is irisin a human exercise gene[J]. Nature, 2012, 488(7413): E9-E10.
[28] 陈秋红,陈旭晖. 饮食控制配合家庭运动对妊娠期糖尿病孕妇妊娠结局的影响[J]. 深圳中西医结合杂志,2021,31(20): 37-40.
[29] 贺荣荣,樊阳阳,张莉莉,等. 饮食运动干预联合格列本脲对妊娠期糖尿病患者血糖控制及新生儿结局的影响[J]. 现代生物医学进展,2021,21(10): 1878-1882,1805.
[30] XIN C, LIU J, ZHANG J, et al. Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway[J]. International Journal of Obesity, 2016, 40: 443-451.
[31] LIU T Y, SHI C X, GAO R, et al. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes[J]. Clinical Science, 2015, 129(10): 839-850.
[32] LIU T Y, XIONG X Q, REN X S, et al. FNDC5 alleviates hepatosteatosis by restoring AMPK/mTOR-mediated autophagy, fatty acid oxidation, and lipogenesis in mice[J]. Diabetes, 2016, 65(11): 3262-3275.
[33] LI H, ZHANG Y, WANG F, et al. Effects of irisin on the differentiation and browning of human visceral white adipocytes[J]. American Journal of Translational Research, 2019, 11(12): 7410-7421.?/div>